← Evidence map

ReviewTherapeutic advances in rare disease

Access to drugs for rare diseases (DRD) in Canada: a comprehensive review of the provincial DRD-specific programs.

Nahya AwadaPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

Not cited yet

Full record →Abstract, authors, funding and every citing paper · PMID 40302781